Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 134.72B | 137.18B | 130.04B | 122.75B | 137.65B | 136.01B |
Gross Profit | 38.59B | 37.91B | 37.20B | 35.16B | 36.77B | 35.87B |
EBITDA | 6.31B | 7.98B | 7.42B | 6.05B | 7.49B | 7.33B |
Net Income | 3.63B | 4.13B | 3.58B | 1.61B | 3.90B | 1.55B |
Balance Sheet | ||||||
Total Assets | 58.55B | 57.70B | 52.18B | 47.34B | 48.69B | 47.21B |
Cash, Cash Equivalents and Short-Term Investments | 15.22B | 13.46B | 12.69B | 9.04B | 11.58B | 10.62B |
Total Debt | 13.67B | 12.75B | 11.80B | 11.64B | 12.19B | 13.42B |
Total Liabilities | 32.93B | 30.84B | 28.91B | 27.28B | 29.14B | 30.95B |
Stockholders Equity | 25.62B | 26.86B | 23.27B | 20.06B | 19.54B | 16.26B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.60B | 3.63B | -557.00M | 2.86B | 4.75B |
Operating Cash Flow | 0.00 | 5.32B | 7.36B | 3.33B | 6.13B | 6.80B |
Investing Cash Flow | 0.00 | -3.05B | -3.29B | -4.20B | -3.27B | -1.19B |
Financing Cash Flow | 0.00 | -1.45B | -423.00M | -1.68B | -1.90B | -702.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥28.77B | 6.88 | 2.37% | 5.49% | 14.96% | ||
80 Outperform | ¥19.09B | 6.22 | 4.26% | 7.08% | -1.44% | ||
75 Outperform | ¥16.97B | 12.04 | 2.42% | 3.22% | 7.14% | ||
70 Outperform | ¥33.45B | 7.42 | 4.49% | -0.64% | 17.19% | ||
61 Neutral | ¥27.35B | 36.54 | 467.10% | -9.02% | -39.11% | ||
53 Neutral | C$4.46B | 3.86 | -22.83% | 4.40% | 8.13% | 2.00% |